1. Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer. Issue 3 (14th March 2022) Authors: Lheureux, Stephanie; Matei, Daniela E; Konstantinopoulos, Panagiotis A; Wang, Ben X; Gadalla, Ramy; Block, Matthew S; Jewell, Andrea; Gaillard, Stephanie L; McHale, Michael; McCourt, Carolyn; Temkin, Sarah; Girda, Eugenia; Backes, Floor J; Werner, Theresa L; Duska, Linda; Kehoe, Siobhan; Colombo,... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗